These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9972690)

  • 1. Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice.
    Masliah E; Armasolo F; Veinbergs I; Mallory M; Samuel W
    Pharmacol Biochem Behav; 1999 Feb; 62(2):239-45. PubMed ID: 9972690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease.
    Rockenstein E; Ubhi K; Pham E; Michael S; Doppler E; Novak P; Inglis C; Mante M; Adame A; Alvarez XA; Moessler H; Masliah E
    J Neurosci Res; 2011 Nov; 89(11):1812-21. PubMed ID: 21793038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE.
    Masliah E; Samuel W; Veinbergs I; Mallory M; Mante M; Saitoh T
    Brain Res; 1997 Mar; 751(2):307-14. PubMed ID: 9099820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity.
    Veinbergs I; Mante M; Mallory M; Masliah E
    J Neural Transm Suppl; 2000; 59():273-80. PubMed ID: 10961439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
    Veinbergs I; Van Uden E; Mallory M; Alford M; McGiffert C; DeTeresa R; Orlando R; Masliah E
    Exp Neurol; 2001 Jul; 170(1):15-26. PubMed ID: 11421580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrolysin in Alzheimer's disease.
    Antón Álvarez X; Fuentes P
    Drugs Today (Barc); 2011 Jul; 47(7):487-513. PubMed ID: 22013558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
    Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
    J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease.
    Rockenstein E; Mallory M; Mante M; Alford M; Windisch M; Moessler H; Masliah E
    J Neural Transm Suppl; 2002; (62):327-36. PubMed ID: 12456076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease.
    Bae CY; Cho CY; Cho K; Hoon Oh B; Choi KG; Lee HS; Jung SP; Kim DH; Lee S; Choi GD; Cho H; Lee H
    J Am Geriatr Soc; 2000 Dec; 48(12):1566-71. PubMed ID: 11129744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked hippocampal neuronal damage without motor deficits after mild concussive-like brain injury in apolipoprotein E-deficient mice.
    Han SH; Chung SY
    Ann N Y Acad Sci; 2000 Apr; 903():357-65. PubMed ID: 10818526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [ApoE genotype and efficacy of neurotrophic and cholinergic therapy in Alzheimer's disease].
    Gavrilova SI; Kolykhalov IV; Korovaĭtseva GI; Zharikov GA; Kalyn IaB; Selezneva ND
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(4):27-34. PubMed ID: 15880838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [4th International Symposium. "Cerebrolysin: pharmacological effects and role in clinical practice"].
    Gomazkov OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):69-70. PubMed ID: 12378888
    [No Abstract]   [Full Text] [Related]  

  • 14. Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study.
    Alvarez XA; Sampedro C; Pérez P; Laredo M; Couceiro V; Hernández A; Figueroa J; Varela M; Arias D; Corzo L; Zas R; Lombardi V; Fernández-Novoa L; Pichel V; Cacabelos R; Windisch M; Aleixandre M; Moessler H
    Int Clin Psychopharmacol; 2003 Sep; 18(5):271-8. PubMed ID: 12920387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased density of glutamate receptor subunit 1 due to Cerebrolysin treatment: an immunohistochemical study on aged rats.
    Eder P; Reinprecht I; Schreiner E; Skofitsch G; Windisch M
    Histochem J; 2001; 33(11-12):605-12. PubMed ID: 12197668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and cognitive studies of apolipoprotein-E-deficient mice.
    Gordon I; Genis I; Grauer E; Sehayek E; Michaelson DM
    Mol Chem Neuropathol; 1996; 28(1-3):97-103. PubMed ID: 8871947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological approaches to the therapy of Alzheimer's disease].
    Gavrilova SI
    Vestn Ross Akad Med Nauk; 2006; (9-10):30-4. PubMed ID: 17111921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice.
    Veinbergs I; Mallory M; Sagara Y; Masliah E
    Eur J Neurosci; 2000 Dec; 12(12):4541-6. PubMed ID: 11122365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synaptotagmin and synaptic transmission alterations in apolipoprotein E-deficient mice.
    Veinbergs I; Mante M; Jung MW; Van Uden E; Masliah E
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Apr; 23(3):519-31. PubMed ID: 10378234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjects.
    Alvarez XA; Lombardi VR; Corzo L; Pérez P; Pichel V; Laredo M; Hernández A; Freixeiro F; Sampedro C; Lorenzo R; Alcaraz M; Windisch M; Cacabelos R
    J Neural Transm Suppl; 2000; 59():315-28. PubMed ID: 10961443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.